Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: the first study in Jordan

Authors

  • Dua’a Jarajreh Faculty of Science, Mu’tah University, Alkarak, Jordan
  • Amin Aqel Faculty of Medicine, Mu’tah University, Alkarak, Jordan
  • Hamed Alzoubi Faculty of Medicine, Mu’tah University, Alkarak, Jordan
  • Wael Al-Zereini Faculty of Science, Mu’tah University, Alkarak, Jordan

DOI:

https://doi.org/10.3855/jidc.8316

Keywords:

Clindamycin resistance, iMLSB, MRSA

Abstract

Introduction: A high rate of infections with methicillin-resistant Staphylococcus aureus (MRSA) has been documented, in both hospital- (HA-MRSA) and community-acquired (CA-MRSA) diseases in Jordan. Erythromycin and clindamycin are considered treatments of choice. However, resistance to erythromycin with false susceptibility to clindamycin in vitro may lead to therapeutic failure. Hence, it is mandatory to study the prevalence of inducible resistance to macrolide-lincosamide-streptogramin B (iMLSB) antibiotics conferred by erm genes in those bacteria.

Methodology: S. aureus isolates were identified morphologically and biochemically, and MRSA were appraised using standard procedures. Induction in resistance to MLSB antibiotics among MRSA isolates was detected phenotypically using the D-test, and the presence of erm genes was revealed by polymerase chain reaction (PCR).

Results: Of 126 collected Staphylococcus isolates, 71 (56.3%) isolates were S. aureus, of which 55 (77.5%) were MRSA. A total of 43 (78.2%) MRSA-discordant isolates were resistant to erythromycin, of which 33 (76.7%) exhibited the iMLSB (D-test positive), 2 (4.7%) the MSB (D-test negative), and 8 (18.6%) the constitutive resistant (cMLSB) phenotypes. Induction of clindamycin resistance was 1.6 times greater in CA-MRSA than in HA-MRSA. Furthermore, ermA and ermC were significantly prevalent in HA-MRSA and CA-MRSA, respectively.

Conclusions: Continuous surveillance of the MLSB resistance is important and required before the prescription of clindamycin to treat MRSA infections.

Author Biographies

Dua’a Jarajreh, Faculty of Science, Mu’tah University, Alkarak, Jordan

Biological Sciences Department, Faculty of Science

Amin Aqel, Faculty of Medicine, Mu’tah University, Alkarak, Jordan

Associate Professor/ Microbiology and Immunology Department, Faculty of Medicine

 

Hamed Alzoubi, Faculty of Medicine, Mu’tah University, Alkarak, Jordan

Associate Professor/ Microbiology and Immunology Department, Faculty of Medicine

Wael Al-Zereini, Faculty of Science, Mu’tah University, Alkarak, Jordan

Associate Professor/ Biological Sciences Department, Faculty of Science

Downloads

Published

2017-04-30

How to Cite

1.
Jarajreh D, Aqel A, Alzoubi H, Al-Zereini W (2017) Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: the first study in Jordan. J Infect Dev Ctries 11:350–354. doi: 10.3855/jidc.8316

Issue

Vol. 11 No. 04: April 2017

Section

Brief Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC